» Articles » PMID: 12393397

ADAMTS-13 Rapidly Cleaves Newly Secreted Ultralarge Von Willebrand Factor Multimers on the Endothelial Surface Under Flowing Conditions

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Oct 24
PMID 12393397
Citations 339
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombotic thrombocytopenic purpura (TTP) is a devastating thrombotic disorder caused by widespread microvascular thrombi composed of platelets and von Willebrand factor (VWF). The disorder is associated with a deficiency of the VWF-cleaving metalloprotease, ADAMTS-13, with consequent accumulation of ultralarge (UL) VWF multimers in the plasma. ULVWF multimers, unlike plasma forms of VWF, attach spontaneously to platelet GP Ibalpha, a component of the GP Ib-IX-V complex. We have found that ULVWF multimers secreted from stimulated endothelial cells (ECs) remained anchored to the endothelial surface where platelets and Chinese hamster ovary cells expressing the GP Ib-IX-V complex attached to form long beads-on-a-string structures in the presence of fluid shear stresses in both the venous (2.5 dyne/cm(2)) and arterial (20 and 50 dyne/cm(2)) ranges. Although measurement of the activity of the ADAMTS-13 VWF-cleaving metalloprotease in vitro requires prolonged incubation of the enzyme with VWF under nonphysiologic conditions, EC-derived ULVWF strings with attached platelets were cleaved within seconds to minutes in the presence of normal plasma (containing approximately 100% ADAMTS-13 activity) or in the presence of partially purified ADAMTS-13. By contrast, the strings persisted for the entire period of perfusion (10 minutes) in the presence of plasma from patients with TTP containing 0% to 10% ADAMTS-13 activity. These results suggest that cleavage of EC-derived ULVWF multimers by ADAMTS-13 is a rapid physiologic process that occurs on endothelial cell surfaces.

Citing Articles

Von Willebrand factor and hematogenous cancer metastasis under flow.

Xu W, Tan X, Li M, Xu H, Villegas J, Fu H Front Cell Dev Biol. 2024; 12:1435718.

PMID: 39282473 PMC: 11401050. DOI: 10.3389/fcell.2024.1435718.


Clinical Utility of Recently Food and Drug Administration-Approved IntelliSep Test (Sepsis Biomarker) for Early Diagnosis of Sepsis: Comparison with Other Biomarkers.

Sarani N, Dasgupta A, Enders M, Rowan L, Elsarraj H, Gralnek S J Clin Med. 2024; 13(16).

PMID: 39200994 PMC: 11355800. DOI: 10.3390/jcm13164852.


Animal models for thrombotic thrombocytopenic purpura: a narrative review.

Zheng L, Zheng X Ann Blood. 2024; 8.

PMID: 39148951 PMC: 11326488. DOI: 10.21037/aob-22-18.


Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review.

Liu S, Zheng X Ann Blood. 2024; 8.

PMID: 39100389 PMC: 11296612. DOI: 10.21037/aob-22-29.


von Willebrand disease.

Seidizadeh O, Eikenboom J, Denis C, Flood V, James P, Lenting P Nat Rev Dis Primers. 2024; 10(1):51.

PMID: 39054329 DOI: 10.1038/s41572-024-00536-8.